Cargando…
The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model
BACKGROUND: Breast cancer is the most frequently diagnosed cancer in women in the United States. Approximately 70% of breast cancers are diagnosed in postmenopausal women. Major clinical trials and experimental studies showed that aromatase inhibitors are effective against postmenopausal breast canc...
Autores principales: | Arumugam, Arunkumar, Lissner, Elaine A, Lakshmanaswamy, Rajkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110932/ https://www.ncbi.nlm.nih.gov/pubmed/25023195 http://dx.doi.org/10.1186/1477-7827-12-66 |
Ejemplares similares
-
Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide
por: Arumugam, Arunkumar, et al.
Publicado: (2021) -
Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
por: Subramani, Ramadevi, et al.
Publicado: (2014) -
Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
por: Arumugam, Arunkumar, et al.
Publicado: (2019) -
Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
por: Subramani, Ramadevi, et al.
Publicado: (2014) -
Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant
por: Kümler, Iben, et al.
Publicado: (2016)